Inventor
ABDICHE YASMINA NOUBIA
US24 patents
⚠️ This page may combine multiple inventors who share the name “ABDICHE YASMINA NOUBIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LABRYS BIOLOG INC
8 patentsUS8734802B1May 27, 2014
Methods of treating vasomotor symptoms using antibodies
LABRYS BIOLOG INC54 citations98
US8597649B2Dec 3, 2013
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC51 citations98
US9266951B2Feb 23, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC23 citations96
US9115194B2Aug 25, 2015
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC26 citations96
US9365648B1Jun 14, 2016
Methods of using anti-CGRP antagonist antibodies
LABRYS BIOLOG INC16 citations92
US9346881B2May 24, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC16 citations92
US9340614B2May 17, 2016
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
LABRYS BIOLOG INC16 citations92
US9328168B2May 3, 2016
Methods of using anti-CGRP antagonist antibodies
LABRYS BIOLOG INC16 citations92
RINAT NEUROSCIENCE CORP
5 patentsUS8007794B2Aug 30, 2011
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
RINAT NEUROSCIENCE CORP51 citations97
US10155037B2Dec 18, 2018
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP18 citations93
US9175093B2Nov 3, 2015
PCSK9 antagonists
RINAT NEUROSCIENCE CORP6 citations83
US10660953B2May 26, 2020
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP2 citations71
US11338035B2May 24, 2022
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP0 citations61
TEVA PHARMACEUTICALS INT GMBH
5 patentsUS9890211B2Feb 13, 2018
Antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH11 citations92
US9890210B2Feb 13, 2018
Antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH11 citations92
US9884908B2Feb 6, 2018
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH15 citations92
US9884907B2Feb 6, 2018
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH15 citations92
US10329343B2Jun 25, 2019
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
TEVA PHARMACEUTICALS INT GMBH5 citations84
LIANG HONG
3 patentsUS8080243B2Dec 20, 2011
Isolated antibody which specifically binds to PCSK9
LIANG HONG139 citations97
US8426363B2Apr 23, 2013
Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9
LIANG HONG58 citations96
US8399646B2Mar 19, 2013
Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody
LIANG HONG57 citations96